Tuberculosis in Pakistan: What Every Patient Must Know

Published on April 26, 2026

Tuberculosis in Pakistan: What Every Patient Must Know
Infectious Lung Disease & Public Health

Tuberculosis in Pakistan: What Every Patient Must Know

Pakistan carries one of the heaviest tuberculosis burdens in the world — yet TB remains deeply misunderstood, widely stigmatised, and far too often diagnosed late. A pulmonologist breaks down the facts, the warning signs, and everything you need to know to protect yourself and your family.

Dr. Nabila Zaheer Pulmonologist & Respiratory Specialist
Published April 26, 2026
Read time 15 min

Of all the diseases I encounter in my pulmonology practice, tuberculosis is the one that carries the heaviest weight — not just medically, but socially. Patients delay seeking help because they fear the stigma of a TB diagnosis. Families hide the illness from neighbours and relatives. Young men and women quietly deteriorate for months before anyone thinks to test for the one condition that is most likely to explain their symptoms.

This silence costs lives. TB is a curable disease — fully, completely curable in the vast majority of cases with a course of medication. The tragedy of TB deaths in Pakistan is not medical. It is a tragedy of late diagnosis, incomplete treatment, and fear. My goal with this article is to replace that fear with knowledge — because a patient who understands TB is a patient who gets tested early, takes their medication properly, and recovers completely.

Pakistan ranks fifth in the world for tuberculosis burden. This is not a statistic to be ashamed of — it is a reality to be confronted honestly and addressed with the urgency it deserves.


5th Pakistan has the 5th highest TB burden globally — over 600,000 new cases estimated every year
40% of TB cases in Pakistan go undetected or unreported — a major driver of continued transmission
95% cure rate for drug-sensitive TB when treatment is completed correctly — TB is fully curable

What Is Tuberculosis?

Tuberculosis is a bacterial infection caused by Mycobacterium tuberculosis — a slow-growing bacterium that most commonly infects the lungs but can spread to almost any organ in the body. It is one of the oldest known human diseases, and despite being both preventable and curable, it remains one of the leading infectious causes of death worldwide.

TB spreads through the air. When a person with active pulmonary TB coughs, sneezes, speaks, or sings, tiny infectious droplets containing the bacteria are released into the air. Anyone who inhales these droplets in sufficient quantity may become infected. Unlike many infectious diseases, TB does not spread through casual contact — touching, sharing food, or using the same utensils does not transmit it. Prolonged close contact in poorly ventilated spaces is the primary route of transmission.

It is critically important to understand the distinction between TB infection and TB disease — because they are not the same thing, and confusing them causes enormous unnecessary anxiety.

Latent TB Infection (LTBI)

When Mycobacterium tuberculosis enters the body, the immune system of most healthy people contains it without allowing it to cause active disease. The bacteria remain alive but dormant — walled off by the immune system. This is called latent TB infection. People with latent TB have no symptoms, are not infectious, and cannot spread TB to others. However, if the immune system is weakened — by HIV, malnutrition, diabetes, immunosuppressive medications, or simply by ageing — the dormant bacteria can reactivate and cause active disease. Approximately 5 to 10 percent of people with latent TB will develop active disease during their lifetime without preventive treatment.

Active TB Disease

Active TB disease occurs when the bacteria multiply beyond the immune system's ability to contain them, causing symptomatic illness. Active pulmonary TB — TB of the lungs — is infectious. Extrapulmonary TB — affecting the lymph nodes, spine, kidneys, brain, or other organs — is generally not infectious but requires the same duration of treatment.


Warning Signs: When to Suspect TB

The symptoms of pulmonary TB develop slowly — typically over several weeks to months. This gradual onset is one of the reasons diagnosis is so often delayed. Patients and their doctors attribute early symptoms to a prolonged chest infection, fatigue, or stress — and the window for early intervention narrows.

🫁
Persistent cough lasting more than 2–3 weeks

The most common and most important symptom. A cough that does not resolve after the expected duration of a chest infection — particularly one that produces sputum — should always raise suspicion for TB in a high-prevalence setting like Pakistan.

🩸
Coughing up blood (haemoptysis)

Even a small amount of blood in the sputum demands urgent medical evaluation. Haemoptysis in TB can range from blood-streaked mucus to significant bleeding. It should never be ignored or attributed to a minor cause without investigation.

🌙
Night sweats

Drenching night sweats that soak clothing and bedding — not simply feeling warm — are a classic constitutional symptom of TB. They result from the body's immune response to the infection and are frequently present for weeks before a diagnosis is made.

🌡️
Low-grade fever

A persistent mild fever — often between 37.5°C and 38.5°C — that is worse in the afternoon and evening. Many patients describe feeling "feverish" rather than having a clearly measurable high temperature, and dismiss it as general unwellness.

⚖️
Unexplained weight loss

Progressive, unintentional weight loss over weeks to months is one of the most consistent features of active TB. The bacterium and the immune response to it consume significant metabolic resources, and appetite is often suppressed by the illness.

😴
Fatigue and general weakness

A profound, bone-deep fatigue that does not improve with rest. Patients often describe being unable to perform daily tasks they previously managed easily. This symptom is frequently attributed to overwork or stress, significantly delaying the diagnosis.

The combination I watch for most carefully in my clinic is simple: a cough lasting more than two weeks, weight loss, and night sweats in a patient from a high-risk background. In Pakistan, that combination means TB until proven otherwise. The investigation is straightforward. The cost of missing it is not.

— Dr. Nabila Zaheer, Pulmonologist

Who Is Most at Risk in Pakistan?

TB does not discriminate — anyone can develop active TB if exposed to a sufficient infectious dose. However, certain factors substantially increase both the risk of infection and the risk of progressing from infection to active disease.

High-Risk Groups in the Pakistani Context

  • Household contacts of active TB patients — people living with or in close daily contact with someone who has active pulmonary TB are at the highest risk of exposure. All household contacts of a newly diagnosed TB patient should be screened, regardless of whether they have symptoms.
  • People living in overcrowded or poorly ventilated conditions — TB thrives where many people share small, enclosed spaces with limited air circulation. Urban slums, dense housing, prisons, and refugee settlements are high-transmission environments.
  • People with HIV or other immunocompromising conditions — HIV is the single strongest risk factor for TB reactivation worldwide. People living with HIV are 18 times more likely to develop active TB than those without HIV.
  • People with diabetes — diabetes is estimated to triple the risk of developing active TB and is associated with worse treatment outcomes. Given the high prevalence of diabetes in Pakistan, this interaction is a significant public health concern.
  • Malnourished individuals — malnutrition impairs immune function and is one of the most important TB risk factors in low-income settings. Undernutrition and TB form a vicious cycle — each worsening the other.
  • Smokers — smoking damages the cilia and mucus defence mechanisms of the airways, increases susceptibility to TB infection, and significantly worsens outcomes in those who develop active TB.
  • Healthcare workers — regular exposure to patients with active TB in clinical settings places healthcare workers at elevated risk, particularly in facilities with inadequate infection control measures.
  • Returning migrants and travellers — people returning from high-burden countries or regions with newly acquired TB exposure may develop active disease months after their return.

Extrapulmonary TB: When TB Attacks Beyond the Lungs

While the lungs are the most common site of TB disease, the bacteria can spread through the bloodstream to virtually any organ. Extrapulmonary TB accounts for approximately 15 to 20 percent of all TB cases and is more common in children and in people with weakened immune systems.

The most common forms of extrapulmonary TB seen in clinical practice include:

  • TB lymphadenitis — the most common extrapulmonary form, causing painless swelling of the lymph nodes, most often in the neck. It is frequently the first sign of TB in children and young adults and is often mistaken for a simple glandular infection.
  • Pleural TB — TB infection of the pleural space around the lungs, causing a pleural effusion (fluid around the lung). It typically presents with breathlessness, chest pain, and fever.
  • Spinal TB (Pott's disease) — TB infection of the vertebrae, causing back pain, spinal deformity, and in severe cases, spinal cord compression and paralysis. It requires prolonged treatment and often surgical intervention.
  • TB meningitis — the most dangerous form of extrapulmonary TB, affecting the membranes surrounding the brain. It presents with headache, fever, confusion, and neck stiffness and is a neurological emergency with high mortality if treatment is delayed.
  • Abdominal TB — affecting the intestines, peritoneum, and abdominal lymph nodes. It presents with abdominal pain, distension, weight loss, and altered bowel habits and is frequently confused with other abdominal conditions.
  • Miliary TB — a severe, disseminated form in which TB spreads throughout the body via the bloodstream, seeding multiple organs simultaneously. It presents with high fever, weight loss, and breathlessness and requires urgent treatment.

How Is TB Diagnosed?

TB diagnosis has advanced significantly in recent years, and Pakistan now has access to several highly accurate diagnostic tools through national TB programmes and private specialist services.

Sputum Smear Microscopy

The traditional first-line test involves examining sputum samples under a microscope for the presence of acid-fast bacilli (AFB). It is inexpensive and widely available, but has limited sensitivity — it misses up to 40 to 50 percent of culture-positive TB cases, particularly in patients with lower bacterial loads.

GeneXpert MTB/RIF (Xpert)

The GeneXpert test has transformed TB diagnosis globally and is now widely available in Pakistan through government programmes and private labs. It uses molecular technology (PCR) to detect TB DNA in a sputum sample within two hours — with far greater sensitivity than smear microscopy — and simultaneously tests for resistance to rifampicin, the most important first-line antibiotic. I consider it the preferred initial diagnostic test in most patients with suspected pulmonary TB.

Sputum Culture

Culturing the TB bacterium from a sputum sample remains the gold standard for diagnosis and is essential for full drug sensitivity testing. It takes two to six weeks to produce results due to the slow growth rate of Mycobacterium tuberculosis, which limits its usefulness for immediate treatment decisions but is critical for detecting drug-resistant strains.

Chest X-Ray

A chest X-ray is a standard part of TB evaluation. It can reveal characteristic changes — upper lobe infiltrates, cavities, hilar lymphadenopathy, or pleural effusion — that raise or lower the suspicion for TB. However, it cannot confirm the diagnosis alone, and both false positives and false negatives occur. A CT scan of the chest provides more detailed information when the X-ray is inconclusive or atypical.

Tuberculin Skin Test (TST) and IGRA

The tuberculin skin test (Mantoux test) and interferon gamma release assays (IGRAs) such as QuantiFERON-TB Gold test for immune sensitisation to TB antigens. They can identify latent TB infection but cannot distinguish latent from active disease. They are most useful for screening high-risk contacts and healthcare workers rather than for diagnosing active TB.


Treatment: TB Is Curable — But Only If You Complete It

This is the most important section of this article — because understanding treatment is what separates a patient who recovers completely from one who develops drug-resistant TB that is far more difficult to cure.

Standard First-Line Treatment — 6 Months

Drug-sensitive TB is treated with a combination of four antibiotics — isoniazid, rifampicin, pyrazinamide, and ethambutol — for the first two months (the intensive phase), followed by isoniazid and rifampicin for four further months (the continuation phase). This six-month course achieves a cure rate of approximately 95 percent when completed correctly. The combination of drugs is essential — treating with a single antibiotic would allow resistant bacteria to survive and multiply.

Why Completing the Full Course Is Non-Negotiable

Patients typically feel significantly better within two to four weeks of starting treatment. This is where the greatest danger lies — feeling better is not the same as being cured. Stopping treatment early leaves surviving bacteria — which are often the most resistant — to multiply unchecked. This is precisely how drug-resistant TB develops. Every case of drug-resistant TB in Pakistan can be traced back to incomplete treatment at some point in its history, either in the current patient or in someone who transmitted it to them. Completing the full six months is not optional. It is what separates a curable disease from a treatment nightmare.

Drug-Resistant TB (DR-TB)

Drug-resistant TB — particularly multidrug-resistant TB (MDR-TB), which is resistant to both isoniazid and rifampicin — is a growing crisis in Pakistan. MDR-TB requires treatment with second-line drugs for 18 to 24 months, carries a lower cure rate, causes more side effects, and is significantly more expensive to treat. Extensively drug-resistant TB (XDR-TB) is resistant to multiple second-line drugs as well and represents a profound treatment challenge. The most effective way to prevent drug resistance is to diagnose TB correctly and complete the first-line course without interruption.

Directly Observed Treatment (DOT)

To ensure treatment completion, the World Health Organisation recommends Directly Observed Treatment — a strategy in which a healthcare worker or trained supporter watches the patient swallow each dose. DOT is available through Pakistan's National TB Control Programme at government health facilities free of charge. It significantly improves treatment completion rates and is associated with lower rates of drug resistance development.

Free TB Treatment in Pakistan

All first-line TB drugs are available free of cost through Pakistan's National TB Control Programme at government hospitals, district health authorities, and designated private sector providers. No patient in Pakistan should fail to complete TB treatment due to the cost of medication. If you or a family member has been diagnosed with TB and is struggling to access free treatment, please ask your pulmonologist or the nearest government health facility for guidance on accessing the national programme.

Nutrition and Supportive Care

Nutritional support is an underappreciated but important component of TB treatment. Malnutrition worsens TB outcomes, and TB itself causes weight loss and nutritional depletion. A high-protein, calorie-adequate diet, vitamin D supplementation, and — where available — nutritional support programmes all improve treatment outcomes and speed recovery. Patients should also be advised on infection control within the household during the infectious period, and household contacts should be screened and offered preventive therapy where appropriate.


The Stigma Problem — And Why It Costs Lives

I want to address this directly, because in my experience it is one of the most significant barriers to TB control in Pakistan — and it is one that medical science alone cannot solve.

TB carries a social stigma in Pakistan that is entirely disproportionate to the reality of the disease. Patients fear that a TB diagnosis will affect their marriage prospects, their employment, their social standing, and their family's reputation. Young people in particular delay seeking help for weeks or months because they are afraid of what the diagnosis might mean socially, even as they become increasingly unwell.

The facts are straightforward: TB is caused by a bacterium, not by weakness, poverty, or moral failing. It is transmitted by breathing shared air — something every human being does. After two weeks of effective treatment, the vast majority of patients are no longer infectious and pose no risk to people around them. A person who has recovered from TB is no different from anyone who has recovered from any other curable infection.

If you have TB, you have a bacterial infection — no different in its fundamental nature from pneumonia or a urinary tract infection. You deserve treatment, support, and the same respect afforded to anyone with a medical condition. And if someone you know has TB, they need your support — not your distance.


Prevention: Protecting Yourself and Your Family

  • BCG vaccination — the BCG vaccine, given at birth in Pakistan as part of the Expanded Programme on Immunisation, provides significant protection against the most severe forms of TB in children — particularly TB meningitis and miliary TB. It does not provide complete protection against pulmonary TB in adults but remains an important preventive tool in high-burden settings.
  • Ventilate your living and working spaces — TB spreads in poorly ventilated, enclosed spaces. Opening windows, improving air circulation, and avoiding prolonged time in crowded, poorly ventilated environments reduces transmission risk significantly.
  • Screen household contacts — if someone in your household is diagnosed with TB, all close contacts should be screened for infection and active disease. Children under five and immunocompromised contacts should be offered preventive therapy (isoniazid preventive therapy or TPT) to reduce the risk of progressing to active disease.
  • Treat latent TB in high-risk individuals — people with latent TB infection who are at high risk of reactivation — those with HIV, diabetes, or on immunosuppressive therapy — should be offered preventive treatment. A six-month course of isoniazid reduces the risk of developing active TB by approximately 60 to 90 percent in those with latent infection.
  • Manage risk factors — controlling diabetes, maintaining good nutrition, stopping smoking, and managing any immunocompromising condition all reduce the risk of progressing from latent infection to active TB disease.
  • Seek early diagnosis — the single most impactful individual action is to seek medical evaluation promptly when symptoms are present, rather than waiting in hope that they resolve. A cough lasting more than two weeks in Pakistan deserves a TB test. Early diagnosis means earlier treatment, faster recovery, and less transmission to others.

TB is the disease that should not still be killing people in 2026. We have the tools to diagnose it quickly, the drugs to cure it completely, and the knowledge to prevent its spread. What we need — in Pakistan and globally — is the collective will to use those tools without shame or delay. Every patient who seeks help early is one less transmission, one more cure, and one step closer to ending this epidemic.

— Dr. Nabila Zaheer, Pulmonologist

Frequently Asked Questions

Can I spread TB to my family while on treatment?

After approximately two weeks of effective treatment, most patients with drug-sensitive pulmonary TB become non-infectious as the bacterial load in their sputum falls dramatically. However, until your doctor confirms you are no longer infectious — based on clinical improvement and sputum test results — you should take precautions: sleep in a separate, well-ventilated room, wear a mask when in close contact with others, and avoid crowded enclosed spaces. Children and immunocompromised family members need particular protection during this initial period.

I was diagnosed with TB two years ago and completed treatment. Can I get TB again?

Yes — having had TB and recovered from it does not provide lasting immunity against reinfection. You can be re-exposed to Mycobacterium tuberculosis from another source and develop active TB again. This is called reinfection and is distinct from relapse of the previous episode. Ongoing precautions — particularly if you are in a high-risk environment — remain relevant even after a successful previous treatment.

My child has swollen glands in the neck. Could it be TB?

TB lymphadenitis — TB of the lymph nodes — is one of the most common forms of extrapulmonary TB and frequently presents as painless, enlarging lymph nodes in the neck in children and young adults. It should always be considered when lymph node enlargement does not resolve within a few weeks, particularly in a child with any TB risk factors or household TB contact. Diagnosis typically requires a fine needle aspiration biopsy (FNAC) or surgical biopsy of the node, and GeneXpert testing of the sample. Do not assume swollen neck glands in a child are simply a glandular infection without ruling out TB.

What should I do if I think I have been exposed to someone with TB?

If you have had prolonged close contact — particularly household contact — with someone confirmed to have active pulmonary TB, you should seek medical evaluation regardless of whether you have symptoms. A chest X-ray and tuberculin skin test or IGRA can assess whether you have been infected. If tests suggest latent TB infection and you are in a high-risk group, your doctor may recommend preventive therapy. Do not wait for symptoms to develop — the purpose of contact screening is to identify and treat infection before it progresses to active disease.

Is TB treatment available for free in Pakistan?

Yes. All first-line anti-TB medications are provided free of charge through Pakistan's National TB Control Programme at government hospitals and designated health facilities across the country. Second-line treatment for drug-resistant TB is also available free through the programme at designated MDR-TB treatment centres. No patient should be unable to access TB treatment due to cost. If you are unsure where to access free treatment in your area, your pulmonologist or the nearest district health office can direct you to the appropriate facility.

A Cough That Will Not Go Away Deserves an Answer

If you or someone in your family has had a cough for more than two weeks — especially with weight loss, night sweats, or fever — please do not wait. TB is curable when caught early. Book a consultation with Dr. Nabila Zaheer at PulmoCare today and get the answers you need.

Book an Appointment
Medical Disclaimer: This article is written for general informational and educational purposes only. It does not constitute medical advice and should not replace a consultation with a qualified healthcare professional. If you are experiencing symptoms described in this article, please seek evaluation from a licensed physician. Dr. Nabila Zaheer is a board-certified pulmonologist at PulmoCare, Rawalpindi — click here to book a consultation.
Back to Articles